Charles River Laboratories | CRL - Trade Debtors

Stock Price
172.83
Daily Change
-2.24 -1.28%
Monthly
3.26%
Yearly
72.92%
Q2 Forecast
168.66

Charles River Laboratories reported $1.43B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agilent USD 1.52B 34M Dec/2025
Align Technology USD 1.1B 2.38M Dec/2025
Bio-Rad Laboratories USD 464.7M 5.2M Sep/2025
Bruker USD 544.9M 6M Dec/2025
Cardinal Health USD 13.66B 108M Dec/2025
Charles River Laboratories USD 1.43B 54.59M Dec/2025
Cigna USD 31.71B 3.74B Sep/2025
Concord Medical Services Hldg CNY 57.36M 40.75M Jun/2025
CVS Health USD 39.78B 4.08B Dec/2025
Danaher USD 3.91B 762M Dec/2025
Dentsply International USD 688M 34M Dec/2025
Elevance Health USD 21.54B 807M Dec/2025
Galapagos EUR 199.75M 122.08M Dec/2025
Hologic USD 584.2M 16.6M Dec/2025
Humana USD 3.27B 586M Dec/2025
Illumina USD 854M 125M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Intrexon USD 1.02M 559K Jun/2024
IQVIA Holdings USD 3.43B 113M Dec/2025
Laboratory Of America USD 2.26B 4.5M Dec/2025
Lonza CHF 1.78B 55M Dec/2025
McKesson USD 28.21B 73M Dec/2025
Merck EUR 4.44B 293M Dec/2025
Mettler Toledo International USD 778.24M 90.98M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Quest Diagnostics USD 1.41B 48M Dec/2025
Revvity USD 744.67M 64.41M Dec/2025
Thermo Fisher Scientific USD 8.9B 11M Dec/2025
United Therapeutics USD 350.2M 52.5M Dec/2025
UnitedHealth USD 23.02B 346M Dec/2025
Veradigm USD 175.72M 58.76M Dec/2022
Waters USD 828.84M 80.32M Dec/2025
West Pharmaceutical Services USD 574.4M 50.6M Dec/2025